Top Markets
#1 Derive Derive +33.13%
#2 Cross Cross +16.48%
#3 Geodnet Geodnet +10.63%
#4 Gama Token Gama Token +9.17%
#5 The Bitcoin Bull The Bitcoin Bull +8.05%
#6 Steakhouse ETH Morpho Vault Steakhouse ETH Morpho Vault +7.25%
#7 Quantum Resistant Ledger Quantum Resistant Ledger +6.82%
#8 Cap Cap +6.78%
#9 Humanity Humanity +6.62%
#10 Starpower Starpower +5.78%
Coin of the day
Derive Derive
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
National Graphite Corp. National Graphite Corp.

National Graphite Corp.

NGRC
Kedudukan dalam Saham #35948
National Graphite Corp. (NGRC), operating through its subsidiary Biotech... National Graphite Corp. (NGRC), operating through its subsidiary Biotech Development Corp., functions as a biopharmaceutical enterprise specializing in risk and cost-sharing models. The company establishes partnerships with clinical-stage firms dedicated to developing novel biological entities or innovative therapeutic platforms. These collaborations aim to address a wide spectrum of health conditions, encompassing common illnesses, rare disorders, and those with significant unmet medical requirements. Among its key pipeline developments is ELAFIN, a drug candidate identified as a human-identical protein. ELAFIN is being developed specifically for the management of postoperative inflammatory complications. The advancement of ELAFIN is further supported by a collaboration agreement with Proteo Inc. Founded in 2006, National Graphite Corp. was formerly known as Lucky Boy Silver Corporation until it officially adopted its current name in May 2012. The company maintains its operational headquarters in Duesseldorf, Germany.
Harga Saham
$0.021
Disegerakkan terakhir: 2026-08-13
Modal Pasaran
$3.24M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
-46.15%
Negara
US
Perdagangan National Graphite Corp. (NGRC)

Kategori

Financial Services
Nisbah P/E bagi National Graphite Corp. (NGRC)
Nisbah P/E pada 2026 TTM: 0
Menurut laporan kewangan dan harga saham terkini National Graphite Corp., nisbah P/E semasa (TTM) ialah 0. Pada akhir 2026, syarikat mempunyai nisbah P/E sebanyak 0.
Sejarah nisbah P/E bagi National Graphite Corp. dari 2026 hingga 2026
Nisbah P/E pada akhir setiap tahun
Tahun Nisbah P/E Ubah
Tidak cukup data untuk tarikh yang disediakan.
Nisbah P/E untuk syarikat serupa atau pesaing
Syarikat Nisbah P/E Perbezaan Nisbah P/E Negara
Clone Algo Technologies Inc. Clone Algo Technologies Inc.
Clone Algo Technologies Inc.
CATI.US
 - -
US
Worldwide Webb Acquisition Corp. Worldwide Webb Acquisition Corp.
Worldwide Webb Acquisition Corp.
WWAC.US
 - -
US
Gushen, Inc. Gushen, Inc.
Gushen, Inc.
GSHN.US
 - -
CN
Apollo Strategic Growth Capital Apollo Strategic Growth Capital
Apollo Strategic Growth Capital
APSG.US
 - -
US
Digital World Acquisition Corp. Digital World Acquisition Corp.
Digital World Acquisition Corp.
DWAC.US
 - -
US
Cara membaca nisbah P/E

Nisbah Harga/Perolehan (P/E) mengukur hubungan antara harga saham syarikat dan pendapatan sesaham.
P/E yang rendah tetapi positif menunjukkan syarikat menjana keuntungan tinggi berbanding dengan penilaian semasa dan mungkin dinilai rendah. P/E negatif yang tinggi (hampir 0) menunjukkan kerugian besar.

Syarikat dengan P/E melebihi 30 atau negatif biasanya dilihat sebagai "saham pertumbuhan", bermaksud pelabur menjangkakan pertumbuhan atau keuntungan masa depan.

Syarikat dengan P/E positif di bawah 10 biasanya dianggap sebagai "saham nilai", bermaksud syarikat sudah menguntungkan dan tidak dijangka berkembang pesat.